Article Type
Changed
Tue, 09/13/2022 - 16:55
APN Kametas scans the journals, so you don’t have to!

Marita Kametas, MSN, FNP-BC, CMSRN, COCN
In a study by Creed and colleagues, the presence of psychiatric disorders was the strongest predictor of subsequent irritable bowel syndrome (IBS) diagnosis. This highlights the importance of the brain-gut connection. It also enforces the need for obtaining a comprehensive history during the patient interview and adequate understanding of the patient's psychosocial status. Despite this study being somewhat limited, it does underscore the importance of psychiatric disorders as an important risk factor in the development of IBS.

 

Fecal and mucosal microbiota have been the focus of much research. A study by Hou and colleagues that showed distinct differences in the intestinal and fecal microbiomes of patients with constipation-predominant or diarrhea-predominant IBS, compared with healthy controls, highlights the importance of a balanced and diverse microbiome to maintain a healthy gut. The article notes specific genera of microbiota that were associated with intestinal pain. When microbiota diversity is limited, the incidence of IBS is increased. This reinforces the importance of promoting a healthy microbiome in all patients and appreciating the correlation of the microbiome with the development of IBS.

 Internet-based cognitive-behavioral therapy may make it easier for patients to obtain therapy services. Kim and colleagues have shown this to be a cost-effective and efficacious way to deliver care. This care improves the quality of life for patients with IBS and is an effective intervention that is readily available. During pandemic times, the forum of online care also provides a safe way to deliver therapy services without the burden of the patient needing to commute to clinic and potentially be exposed to infectious disease. Given the relationship between IBS and psychiatric diagnoses noted by Creed and colleagues, it seems important to extend the availability of therapeutic interventions to as many patients with IBS as possible.

Author and Disclosure Information

Marita Kametas, MSN,  FNP-BC, CMSRN, COCN, Advanced Practice Nurse, Department of Digestive Diseases, The University of Chicago Medicine, Chicage, Illinois

APN Kametas is an active member of the Abbvie Speakers’ Bureau

Publications
Topics
Sections
Author and Disclosure Information

Marita Kametas, MSN,  FNP-BC, CMSRN, COCN, Advanced Practice Nurse, Department of Digestive Diseases, The University of Chicago Medicine, Chicage, Illinois

APN Kametas is an active member of the Abbvie Speakers’ Bureau

Author and Disclosure Information

Marita Kametas, MSN,  FNP-BC, CMSRN, COCN, Advanced Practice Nurse, Department of Digestive Diseases, The University of Chicago Medicine, Chicage, Illinois

APN Kametas is an active member of the Abbvie Speakers’ Bureau

APN Kametas scans the journals, so you don’t have to!
APN Kametas scans the journals, so you don’t have to!

Marita Kametas, MSN, FNP-BC, CMSRN, COCN
In a study by Creed and colleagues, the presence of psychiatric disorders was the strongest predictor of subsequent irritable bowel syndrome (IBS) diagnosis. This highlights the importance of the brain-gut connection. It also enforces the need for obtaining a comprehensive history during the patient interview and adequate understanding of the patient's psychosocial status. Despite this study being somewhat limited, it does underscore the importance of psychiatric disorders as an important risk factor in the development of IBS.

 

Fecal and mucosal microbiota have been the focus of much research. A study by Hou and colleagues that showed distinct differences in the intestinal and fecal microbiomes of patients with constipation-predominant or diarrhea-predominant IBS, compared with healthy controls, highlights the importance of a balanced and diverse microbiome to maintain a healthy gut. The article notes specific genera of microbiota that were associated with intestinal pain. When microbiota diversity is limited, the incidence of IBS is increased. This reinforces the importance of promoting a healthy microbiome in all patients and appreciating the correlation of the microbiome with the development of IBS.

 Internet-based cognitive-behavioral therapy may make it easier for patients to obtain therapy services. Kim and colleagues have shown this to be a cost-effective and efficacious way to deliver care. This care improves the quality of life for patients with IBS and is an effective intervention that is readily available. During pandemic times, the forum of online care also provides a safe way to deliver therapy services without the burden of the patient needing to commute to clinic and potentially be exposed to infectious disease. Given the relationship between IBS and psychiatric diagnoses noted by Creed and colleagues, it seems important to extend the availability of therapeutic interventions to as many patients with IBS as possible.

Marita Kametas, MSN, FNP-BC, CMSRN, COCN
In a study by Creed and colleagues, the presence of psychiatric disorders was the strongest predictor of subsequent irritable bowel syndrome (IBS) diagnosis. This highlights the importance of the brain-gut connection. It also enforces the need for obtaining a comprehensive history during the patient interview and adequate understanding of the patient's psychosocial status. Despite this study being somewhat limited, it does underscore the importance of psychiatric disorders as an important risk factor in the development of IBS.

 

Fecal and mucosal microbiota have been the focus of much research. A study by Hou and colleagues that showed distinct differences in the intestinal and fecal microbiomes of patients with constipation-predominant or diarrhea-predominant IBS, compared with healthy controls, highlights the importance of a balanced and diverse microbiome to maintain a healthy gut. The article notes specific genera of microbiota that were associated with intestinal pain. When microbiota diversity is limited, the incidence of IBS is increased. This reinforces the importance of promoting a healthy microbiome in all patients and appreciating the correlation of the microbiome with the development of IBS.

 Internet-based cognitive-behavioral therapy may make it easier for patients to obtain therapy services. Kim and colleagues have shown this to be a cost-effective and efficacious way to deliver care. This care improves the quality of life for patients with IBS and is an effective intervention that is readily available. During pandemic times, the forum of online care also provides a safe way to deliver therapy services without the burden of the patient needing to commute to clinic and potentially be exposed to infectious disease. Given the relationship between IBS and psychiatric diagnoses noted by Creed and colleagues, it seems important to extend the availability of therapeutic interventions to as many patients with IBS as possible.

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: IBS September 2022
Gate On Date
Wed, 06/29/2022 - 18:45
Un-Gate On Date
Wed, 06/29/2022 - 18:45
Use ProPublica
CFC Schedule Remove Status
Wed, 06/29/2022 - 18:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Activity Salesforce Deliverable ID
334012
Activity ID
87195
Product Name
Clinical Edge Journal Scan
Product ID
124
Supporter Name /ID
IBSRELA [6066]